The purpose of this study is to determine if the subjective effects of marijuana will be decreased by low-doses (\< 25 mg) of naltrexone and increased by high-doses (\> 50 mg) of naltrexone.
Age range
21 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Mean Subjective Mood Scores as a Function of Marijuana Strength and Naltrexone Dose.
Timeframe: Baseline compared to 6 week timepoint
Change in Mean Psychomotor Task Performance as a Function of Marijuana Strength and Naltrexone Dose
Timeframe: Baseline compared to 6 week timepoint
Change in Mean Heart Rate as a Function of Marijuana Strength and Naltrexone Dose.
Timeframe: Baseline compared to 6 week timepoint